EXAS Annual FCF
$31.93 M
+$469.95 M+107.29%
31 December 2023
Summary:
As of January 20, 2025, EXAS annual free cash flow is $31.93 million, with the most recent change of +$469.95 million (+107.29%) on December 31, 2023. During the last 3 years, it has fallen by -$39.48 million (-55.28%). EXAS annual FCF is now -55.28% below its all-time high of $71.40 million, reached on December 31, 2020.EXAS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXAS Quarterly FCF
$112.56 M
+$41.36 M+58.09%
30 September 2024
Summary:
As of January 20, 2025, EXAS quarterly free cash flow is $112.56 million, with the most recent change of +$41.36 million (+58.09%) on September 30, 2024. Over the past year, it has increased by +$232.52 million (+193.83%). EXAS quarterly FCF is now at all-time high.EXAS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXAS TTM FCF
$98.43 M
+$113.39 M+757.93%
30 September 2024
Summary:
As of January 20, 2025, EXAS TTM free cash flow is $98.43 million, with the most recent change of +$113.39 million (+757.93%) on September 30, 2024. Over the past year, it has increased by +$118.88 million (+581.16%). EXAS TTM FCF is now at all-time high.EXAS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXAS Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +107.3% | +193.8% | +581.2% |
| 3 y3 years | -55.3% | +241.3% | +265.9% |
| 5 y5 years | +114.6% | +239.5% | +134.6% |
EXAS Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +107.3% | at high | +154.3% | at high | +119.6% |
| 5 y | 5-year | -55.3% | +107.3% | at high | +154.3% | at high | +119.6% |
| alltime | all time | -55.3% | +107.3% | at high | +154.3% | at high | +119.6% |
Exact Sciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $112.56 M(+58.1%) | $98.43 M(-757.9%) |
| June 2024 | - | $71.20 M(-159.4%) | -$14.96 M(-26.9%) |
| Mar 2024 | - | -$119.96 M(-446.4%) | -$20.46 M(-164.1%) |
| Dec 2023 | $31.93 M(-107.3%) | $34.63 M(-4292.1%) | $31.93 M(-235.7%) |
| Sept 2023 | - | -$826.00 K(-101.3%) | -$23.54 M(-78.3%) |
| June 2023 | - | $65.70 M(-197.2%) | -$108.27 M(-63.7%) |
| Mar 2023 | - | -$67.58 M(+224.3%) | -$298.22 M(-31.9%) |
| Dec 2022 | -$438.02 M(+84.0%) | -$20.84 M(-75.6%) | -$438.02 M(-12.6%) |
| Sept 2022 | - | -$85.56 M(-31.1%) | -$501.15 M(+1.2%) |
| June 2022 | - | -$124.24 M(-40.1%) | -$495.23 M(+39.4%) |
| Mar 2022 | - | -$207.38 M(+147.0%) | -$355.23 M(+49.3%) |
| Dec 2021 | -$238.00 M(-433.3%) | -$83.96 M(+5.4%) | -$238.00 M(+301.1%) |
| Sept 2021 | - | -$79.64 M(-605.6%) | -$59.34 M(-167.5%) |
| June 2021 | - | $15.75 M(-117.5%) | $87.95 M(+99.3%) |
| Mar 2021 | - | -$90.15 M(-195.2%) | $44.13 M(-38.2%) |
| Dec 2020 | $71.40 M(-125.1%) | $94.70 M(+40.0%) | $71.40 M(-179.1%) |
| Sept 2020 | - | $67.65 M(-341.0%) | -$90.28 M(-62.2%) |
| June 2020 | - | -$28.07 M(-55.4%) | -$238.59 M(-9.1%) |
| Mar 2020 | - | -$62.88 M(-6.1%) | -$262.37 M(-7.7%) |
| Dec 2019 | -$284.31 M(+29.8%) | -$66.98 M(-17.0%) | -$284.31 M(+5.2%) |
| Sept 2019 | - | -$80.67 M(+55.6%) | -$270.15 M(+9.3%) |
| June 2019 | - | -$51.84 M(-38.9%) | -$247.16 M(-1.1%) |
| Mar 2019 | - | -$84.81 M(+60.6%) | -$249.93 M(+14.1%) |
| Dec 2018 | -$219.03 M(+55.5%) | -$52.82 M(-8.4%) | -$219.03 M(+7.8%) |
| Sept 2018 | - | -$57.68 M(+5.6%) | -$203.24 M(+21.8%) |
| June 2018 | - | -$54.62 M(+1.3%) | -$166.82 M(+5.3%) |
| Mar 2018 | - | -$53.91 M(+45.6%) | -$158.42 M(+12.4%) |
| Dec 2017 | -$140.89 M(-2.8%) | -$37.02 M(+74.1%) | -$140.89 M(+5.4%) |
| Sept 2017 | - | -$21.27 M(-54.0%) | -$133.68 M(-6.6%) |
| June 2017 | - | -$46.22 M(+27.0%) | -$143.13 M(+4.8%) |
| Mar 2017 | - | -$36.38 M(+22.0%) | -$136.56 M(-5.8%) |
| Dec 2016 | -$144.92 M(-7.1%) | -$29.81 M(-2.9%) | -$144.92 M(-5.5%) |
| Sept 2016 | - | -$30.72 M(-22.5%) | -$153.35 M(-6.5%) |
| June 2016 | - | -$39.65 M(-11.4%) | -$163.96 M(+0.6%) |
| Mar 2016 | - | -$44.74 M(+17.0%) | -$163.03 M(+4.5%) |
| Dec 2015 | -$156.00 M(+66.9%) | -$38.25 M(-7.4%) | -$156.00 M(+2.8%) |
| Sept 2015 | - | -$41.32 M(+6.7%) | -$151.68 M(+13.4%) |
| June 2015 | - | -$38.72 M(+2.7%) | -$133.80 M(+17.3%) |
| Mar 2015 | - | -$37.71 M(+11.1%) | -$114.04 M(+22.0%) |
| Dec 2014 | -$93.45 M(+90.6%) | -$33.93 M(+44.8%) | -$93.45 M(+26.0%) |
| Sept 2014 | - | -$23.44 M(+23.5%) | -$74.17 M(+21.3%) |
| June 2014 | - | -$18.97 M(+10.8%) | -$61.17 M(+14.0%) |
| Mar 2014 | - | -$17.11 M(+16.8%) | -$53.64 M(+9.4%) |
| Dec 2013 | -$49.03 M(+8.5%) | -$14.65 M(+40.3%) | -$49.03 M(+8.5%) |
| Sept 2013 | - | -$10.44 M(-8.8%) | -$45.20 M(+0.6%) |
| June 2013 | - | -$11.45 M(-8.4%) | -$44.94 M(-2.9%) |
| Mar 2013 | - | -$12.50 M(+15.5%) | -$46.30 M(+2.4%) |
| Dec 2012 | -$45.20 M | -$10.82 M(+6.4%) | -$45.20 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$10.17 M(-20.6%) | -$43.72 M(+5.0%) |
| June 2012 | - | -$12.81 M(+12.4%) | -$41.63 M(+18.0%) |
| Mar 2012 | - | -$11.40 M(+22.0%) | -$35.28 M(+19.3%) |
| Dec 2011 | -$29.58 M(+110.3%) | -$9.34 M(+15.6%) | -$29.58 M(+20.5%) |
| Sept 2011 | - | -$8.08 M(+25.0%) | -$24.55 M(+20.5%) |
| June 2011 | - | -$6.46 M(+13.4%) | -$20.37 M(+21.9%) |
| Mar 2011 | - | -$5.70 M(+32.1%) | -$16.72 M(+18.9%) |
| Dec 2010 | -$14.07 M(+7.4%) | -$4.31 M(+10.6%) | -$14.07 M(+5.2%) |
| Sept 2010 | - | -$3.90 M(+38.9%) | -$13.37 M(+20.5%) |
| June 2010 | - | -$2.81 M(-7.8%) | -$11.09 M(+21.4%) |
| Mar 2010 | - | -$3.05 M(-15.7%) | -$9.14 M(-30.2%) |
| Dec 2009 | -$13.10 M(+63.6%) | -$3.62 M(+122.5%) | -$13.10 M(+20.3%) |
| Sept 2009 | - | -$1.63 M(+90.5%) | -$10.89 M(-1.4%) |
| June 2009 | - | -$853.00 K(-87.8%) | -$11.05 M(-7.2%) |
| Mar 2009 | - | -$7.01 M(+398.2%) | -$11.91 M(+48.7%) |
| Dec 2008 | -$8.01 M(-10.0%) | -$1.41 M(-20.9%) | -$8.01 M(-11.6%) |
| Sept 2008 | - | -$1.78 M(+3.6%) | -$9.06 M(-5.4%) |
| June 2008 | - | -$1.72 M(-44.8%) | -$9.57 M(+1.0%) |
| Mar 2008 | - | -$3.11 M(+26.5%) | -$9.48 M(+6.5%) |
| Dec 2007 | -$8.90 M(-29.1%) | -$2.46 M(+7.2%) | -$8.90 M(-1.9%) |
| Sept 2007 | - | -$2.29 M(+41.0%) | -$9.07 M(-4.7%) |
| June 2007 | - | -$1.62 M(-35.8%) | -$9.52 M(-11.2%) |
| Mar 2007 | - | -$2.53 M(-3.9%) | -$10.72 M(-14.5%) |
| Dec 2006 | -$12.55 M(-22.6%) | -$2.63 M(-3.9%) | -$12.55 M(-3.3%) |
| Sept 2006 | - | -$2.74 M(-3.2%) | -$12.98 M(-4.4%) |
| June 2006 | - | -$2.83 M(-35.1%) | -$13.58 M(-6.8%) |
| Mar 2006 | - | -$4.35 M(+42.0%) | -$14.58 M(-10.0%) |
| Dec 2005 | -$16.21 M(-23.5%) | -$3.06 M(-8.2%) | -$16.21 M(-10.0%) |
| Sept 2005 | - | -$3.34 M(-12.7%) | -$18.00 M(-8.7%) |
| June 2005 | - | -$3.82 M(-36.1%) | -$19.71 M(-7.4%) |
| Mar 2005 | - | -$5.98 M(+23.1%) | -$21.29 M(+0.4%) |
| Dec 2004 | -$21.20 M(+29.0%) | -$4.86 M(-3.8%) | -$21.20 M(-10.1%) |
| Sept 2004 | - | -$5.05 M(-6.4%) | -$23.59 M(+114.3%) |
| June 2004 | - | -$5.40 M(-8.4%) | -$11.01 M(-18.3%) |
| Mar 2004 | - | -$5.89 M(-18.6%) | -$13.48 M(-18.0%) |
| Dec 2003 | -$16.43 M(+24.0%) | -$7.24 M(-196.2%) | -$16.43 M(-0.5%) |
| Sept 2003 | - | $7.53 M(-195.7%) | -$16.50 M(-46.7%) |
| June 2003 | - | -$7.87 M(-11.1%) | -$30.94 M(+103.1%) |
| Mar 2003 | - | -$8.85 M(+20.9%) | -$15.24 M(+15.0%) |
| Dec 2002 | -$13.25 M(-28.2%) | -$7.32 M(+5.9%) | -$13.25 M(+29.2%) |
| Sept 2002 | - | -$6.91 M(-188.2%) | -$10.26 M(+28.3%) |
| June 2002 | - | $7.84 M(-214.2%) | -$7.99 M(-60.5%) |
| Mar 2002 | - | -$6.86 M(+58.7%) | -$20.26 M(+9.8%) |
| Dec 2001 | -$18.45 M(+110.8%) | -$4.32 M(-6.9%) | -$18.45 M(+30.6%) |
| Sept 2001 | - | -$4.65 M(+4.9%) | -$14.13 M(+49.0%) |
| June 2001 | - | -$4.43 M(-12.4%) | -$9.48 M(+87.6%) |
| Mar 2001 | - | -$5.06 M | -$5.06 M |
| Dec 2000 | -$8.75 M(+78.7%) | - | - |
| Dec 1999 | -$4.90 M | - | - |
FAQ
- What is Exact Sciences annual free cash flow?
- What is the all time high annual FCF for Exact Sciences?
- What is Exact Sciences annual FCF year-on-year change?
- What is Exact Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for Exact Sciences?
- What is Exact Sciences quarterly FCF year-on-year change?
- What is Exact Sciences TTM free cash flow?
- What is the all time high TTM FCF for Exact Sciences?
- What is Exact Sciences TTM FCF year-on-year change?
What is Exact Sciences annual free cash flow?
The current annual FCF of EXAS is $31.93 M
What is the all time high annual FCF for Exact Sciences?
Exact Sciences all-time high annual free cash flow is $71.40 M
What is Exact Sciences annual FCF year-on-year change?
Over the past year, EXAS annual free cash flow has changed by +$469.95 M (+107.29%)
What is Exact Sciences quarterly free cash flow?
The current quarterly FCF of EXAS is $112.56 M
What is the all time high quarterly FCF for Exact Sciences?
Exact Sciences all-time high quarterly free cash flow is $112.56 M
What is Exact Sciences quarterly FCF year-on-year change?
Over the past year, EXAS quarterly free cash flow has changed by +$232.52 M (+193.83%)
What is Exact Sciences TTM free cash flow?
The current TTM FCF of EXAS is $98.43 M
What is the all time high TTM FCF for Exact Sciences?
Exact Sciences all-time high TTM free cash flow is $98.43 M
What is Exact Sciences TTM FCF year-on-year change?
Over the past year, EXAS TTM free cash flow has changed by +$118.88 M (+581.16%)